Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Annals of Laboratory Medicine|July 2, 2014
Risk management in the clinical laboratorySarah W Njoroge, James H NicholsJournal of Lipid Research|November 19, 2011
DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activitySarah W Njoroge, Michael Laposata, Waddah Katrangi, et al.Biochimica Et Biophysica Acta|May 25, 2011
Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosisSarah W Njoroge, Adam C Seegmiller, Waddah Katrangi, et al.The Journal of Nutritional Biochemistry|December 3, 2014
Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturasesSarah W Njoroge, Michael Laposata, Kelli L Boyd, et al.Lipids|May 6, 2011
Increased elongase 6 and Δ9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosisKelly F Thomsen, Michael Laposata, Sarah W Njoroge, et al.Journal of Autoimmunity|May 13, 2011
The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritisAnna E Koh, Sarah W Njoroge, Marianela Feliu, et al.Pageof 1